Cargando…
More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years
Universal access to sexual and reproductive health services is essential to facilitate the empowerment of women and achievement of gender equality. Increasing access to modern methods of contraception can reduce the incidence of unplanned pregnancy and decrease maternal mortality. Long-acting revers...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292574/ https://www.ncbi.nlm.nih.gov/pubmed/33514606 http://dx.doi.org/10.1136/bmjsrh-2020-200962 |
_version_ | 1783724852697366528 |
---|---|
author | Gemzell-Danielsson, Kristina Kubba, Ali Caetano, Cecilia Faustmann, Thomas Lukkari-Lax, Eeva Heikinheimo, Oskari |
author_facet | Gemzell-Danielsson, Kristina Kubba, Ali Caetano, Cecilia Faustmann, Thomas Lukkari-Lax, Eeva Heikinheimo, Oskari |
author_sort | Gemzell-Danielsson, Kristina |
collection | PubMed |
description | Universal access to sexual and reproductive health services is essential to facilitate the empowerment of women and achievement of gender equality. Increasing access to modern methods of contraception can reduce the incidence of unplanned pregnancy and decrease maternal mortality. Long-acting reversible contraceptives (LARCs) offer high contraceptive efficacy as well as cost-efficacy, providing benefits for both women and healthcare systems. The levonorgestrel-releasing intrauterine system (LNG-IUS) first became available in 1990 with the introduction of Mirena (LNG-IUS 20), a highly effective contraceptive which can reduce menstrual blood loss and provide other therapeutic benefits. The impact of the LNG-IUS on society has been wide ranging, including decreasing the need for abortion, reducing the number of surgical sterilisation procedures performed, as well as reducing the number of hysterectomies carried out for issues such as heavy menstrual bleeding (HMB). In the context of the COVID-19 pandemic, Mirena can provide a treatment option for women with gynaecological issues such as HMB without organic pathology, minimising exposure to the hospital environment and reducing waiting times for surgical appointments. Looking to the future, research and development in the field of the LNG-IUS continues to expand our understanding of these contraceptives in clinical practice and offers the potential to further expand the choices available to women, allowing them to select the option that best meets their needs. |
format | Online Article Text |
id | pubmed-8292574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82925742021-08-05 More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years Gemzell-Danielsson, Kristina Kubba, Ali Caetano, Cecilia Faustmann, Thomas Lukkari-Lax, Eeva Heikinheimo, Oskari BMJ Sex Reprod Health Personal View Universal access to sexual and reproductive health services is essential to facilitate the empowerment of women and achievement of gender equality. Increasing access to modern methods of contraception can reduce the incidence of unplanned pregnancy and decrease maternal mortality. Long-acting reversible contraceptives (LARCs) offer high contraceptive efficacy as well as cost-efficacy, providing benefits for both women and healthcare systems. The levonorgestrel-releasing intrauterine system (LNG-IUS) first became available in 1990 with the introduction of Mirena (LNG-IUS 20), a highly effective contraceptive which can reduce menstrual blood loss and provide other therapeutic benefits. The impact of the LNG-IUS on society has been wide ranging, including decreasing the need for abortion, reducing the number of surgical sterilisation procedures performed, as well as reducing the number of hysterectomies carried out for issues such as heavy menstrual bleeding (HMB). In the context of the COVID-19 pandemic, Mirena can provide a treatment option for women with gynaecological issues such as HMB without organic pathology, minimising exposure to the hospital environment and reducing waiting times for surgical appointments. Looking to the future, research and development in the field of the LNG-IUS continues to expand our understanding of these contraceptives in clinical practice and offers the potential to further expand the choices available to women, allowing them to select the option that best meets their needs. BMJ Publishing Group 2021-07 2021-01-29 /pmc/articles/PMC8292574/ /pubmed/33514606 http://dx.doi.org/10.1136/bmjsrh-2020-200962 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Personal View Gemzell-Danielsson, Kristina Kubba, Ali Caetano, Cecilia Faustmann, Thomas Lukkari-Lax, Eeva Heikinheimo, Oskari More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years |
title | More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years |
title_full | More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years |
title_fullStr | More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years |
title_full_unstemmed | More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years |
title_short | More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years |
title_sort | more than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years |
topic | Personal View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292574/ https://www.ncbi.nlm.nih.gov/pubmed/33514606 http://dx.doi.org/10.1136/bmjsrh-2020-200962 |
work_keys_str_mv | AT gemzelldanielssonkristina morethanjustcontraceptiontheimpactofthelevonorgestrelreleasingintrauterinesystemonpublichealthover30years AT kubbaali morethanjustcontraceptiontheimpactofthelevonorgestrelreleasingintrauterinesystemonpublichealthover30years AT caetanocecilia morethanjustcontraceptiontheimpactofthelevonorgestrelreleasingintrauterinesystemonpublichealthover30years AT faustmannthomas morethanjustcontraceptiontheimpactofthelevonorgestrelreleasingintrauterinesystemonpublichealthover30years AT lukkarilaxeeva morethanjustcontraceptiontheimpactofthelevonorgestrelreleasingintrauterinesystemonpublichealthover30years AT heikinheimooskari morethanjustcontraceptiontheimpactofthelevonorgestrelreleasingintrauterinesystemonpublichealthover30years |